Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1100 µg Brimonidine Tartrate Implant
(D07540)		[1] Brimonidine[1] Brimonidine (D07540) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬
2200 µg Brimonidine Tartrate Implant
(D07540)		[1] Brimonidine[1] Brimonidine (D07540) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬
3400 µg Brimonidine Tartrate Implant
(D07540)		[1] Brimonidine[1] Brimonidine (D07540) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬
4Brimonidine
(D07540)		[1] Brimonidine[1] Brimonidine (D07540) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
5Brimonidine tartrate
(D07540)		[1] Brimonidine[1] Brimonidine (D07540) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
6Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System
(D07540)		[1] Brimonidine[1] Brimonidine (D07540) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬